Stay updated on Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Sign up to get notified when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.5.4 to v3.5.5, reflecting a small update to the page's documentation/version metadata.
    Difference
    0.0%
    Check dated 2026-06-06T23:38:01.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.5.4' appears, replacing the previous 'Revision: v3.5.3'. This indicates a minor update to the page's record rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-05-16T10:29:24.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page’s displayed software/document revision identifier was updated from v3.5.2 to v3.5.3 without changing the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-24T22:20:31.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T14:15:30.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Study Protocol and Statistical Analysis Plan document version updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T23:21:29.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. No user-facing content appears to be changed.
    Difference
    0.0%
    Check dated 2026-03-11T18:05:24.000Z thumbnail image

Stay in the know with updates to Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.